Legal Opinion
AstraZeneca Pharmaceuticals LP v. Mylan Pharmaceuticals Inc.
District Court, D. Delaware
Decided June 29, 2010No. MDL No. 08-1949-JJF; Civil Action Nos. 07-805-JJF-LPS, 07-806-JJF-LPS, 07-807-JJF-LPS, 07-808-JJF-LPS, 07-809-JJF-LPS, 07-810-JJF-LPS, 07-811-JJF-LPS, 08-359-JJF-LPS, 08-426-JJF-LPSPublishedCited by 3 opinions
1Opinion of the Court
MEMORANDUM OPINION
FARNAN, District Judge.
AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, IPR Pharmaceuti*393cals Inc. and Shionogi Seiyaku Kabushiki Kaisha (collectively, “Plaintiffs”) brought this action against several different generic drug manufacturers, Mylan Pharmaceuticals Inc., Sun Pharmaceutical Industries, Ltd., Par Pharmaceutical, Inc., Apotex Corp., Aurobindo Pharma Ltd., Cobalt Pharmaceuticals Inc., Cobalt Laboratories Inc., Teva Pharmaceuticals USA, Inc. (collectively, “Defendants”)1 alleging infringement of U.S. Patent No. RE 37,314 (the “'314 patent”), covering…
2Cases cited40 opinions
- Steel Co. v. Citizens for a Better EnvironmentSupreme Court of the United States · 1998
- Valley Forge Christian College v. Americans United for Separation of Church and State, Inc.Supreme Court of the United States · 1982
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Kingsdown Medical Consultants, Ltd. And E.R. Squibb & Sons, Inc. v. Hollister IncorporatedCourt of Appeals for the Federal Circuit · 1988
35 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- In Re Rosuvastatin Calcium Patent LitigationDistrict Court, D. Delaware · 2010
- AstraZeneca UK Ltd. v. Aurobindo Pharma Ltd.Court of Appeals for the Federal Circuit · 2012
- AstraZeneca UK Ltd. v. Aurobindo Pharma Ltd.Court of Appeals for the Federal Circuit · 2012